Shoreline Biome announces international distribution partnership in Japan
January 7, 2020
FARMINGTON, Conn.— Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, has announced a distribution partnership with TOMY Digital Biology Co., Ltd., a leading Japanese biotech organization. TOMY provides high-quality instruments and services to industry segments including biotechnology, biological engineering, medical science, and food [...]
Cover open beakers and bottles securely with a colorful, stretchable lid
January 7, 2020
KIMBLE® Silicon Lids protect precious samples on a wide range of laboratory vessels while adding a splash of color to your lab MILLVILLE, NJ – Using aluminum foil or plastic wrap to cap beakers and flasks has always been a quick fix with questionable effectiveness. The new KIMBLE® Silicone Lids stretch and conform to beaker tops for [...]
CytomX Therapeutics Deploys Genedata Bioprocess
January 7, 2020
CytomX implements off-the-shelf Genedata workflow platform to accelerate development and manufacture of proprietary biotherapeutic modalities for cancer treatment SAN FRANCISCO (PRWEB) -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, has licensed Genedata Bioprocess® to act as an integrated workflow backbone for its [...]
January 7, 2020
License agreement expands New England Biolabs’ rights to use and sell CRISPR/Cas9 reagents and tools DUBLIN, Ireland, and Ipswich MA, USA : ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with New England Biolabs (NEB®), [...]
Redesign Science and OpenEye Scientific announce strategic partnership
January 7, 2020
Partnership will advance both firms' positions in the field of molecular dynamics-based drug discovery NEW YORK and SANTA FE, N.M. -- Redesign Science and OpenEye Scientific are pleased to announce that they have entered into a strategic partnership to integrate OpenEye's pioneering Orion computational platform into Redesign's drug discovery platform. The practice of drug discovery has radically transformed [...]
January 7, 2020
genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system Lyon, France - genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic alliance with Merck, a leading science and technology company and leader in genome editing. In December 2018, genOway [...]
TwinStrand Biosciences Accelerates Commercialization with $16M in Series A Funding
January 7, 2020
SEATTLE -- TwinStrand Biosciences™, a novel genetic sequencing technology company, today announced the close of $16 million in Series A funding, including $12 million in new capital. Madrona Venture Group led the investment with participation from Alexandria Venture Investments, Ridgeback Capital and Sahsen Ventures. The funding will be used to accelerate the company's commercial pipeline, as well as to [...]
ArcherDX Appoints Mark Massaro Chief Financial Officer
January 7, 2020
BOULDER, Colo.— ArcherDX, Inc., a molecular diagnostics company developing breakthrough solutions to advance and enable the practice of personalized genomic medicine, today announced Mark Massaro has been appointed Chief Financial Officer. Mark Massaro, ArcherDX Chief Financial Officer “We are thrilled to welcome Mark to the ArcherDX team,” said Jason Myers, Chief Executive Officer. “Mark’s extensive [...]
TRILINK BIOTECHNOLOGIES EXPANDS IP PORTFOLIO WITH TWO NEW PATEN
January 7, 2020
Advancements Expected to Accelerate Development of mRNA Therapeutics SAN DIEGO – TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids such as DNA and RNA, announced today that the United States Patent and Trademark Office has issued two new patents to the company. Both patents cover advancements in TriLink’s [...]
Paul Netzsch to expand the Executive Board of the NETZSCH Group
January 7, 2020
Selb – Paul Netzsch will be appointed Member of the Executive Board of Erich NETZSCH GmbH & Co. Holding KG as of 1 April 2020. With the 33-year-old business economist, one more member of the shareholder family will head the NETZSCH Group. In the future, Paul Netzsch along with Moritz Netzsch and Jens Niessner with [...]

